Predictors for major cardiovascular outcomes in stable ischaemic heart disease (PREMAC): statistical analysis plan for data originating from the CLARICOR (clarithromycin for patients with stable coronary heart disease) trial
© The Author(s) 2017
Received: 22 September 2016
Accepted: 11 January 2017
Published: 29 March 2017
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|22 Sep 2016||Submitted||Original manuscript|
|7 Oct 2016||Reviewed||Reviewer Report - Johanna Damen|
|19 Oct 2016||Reviewed||Reviewer Report - Ben Van Calster|
|26 Oct 2016||Reviewed||Reviewer Report - Bilal Majed|
|24 Nov 2016||Author responded||Author comments - Per Winkel|
|Resubmission - Version 2|
|24 Nov 2016||Submitted||Manuscript version 2|
|30 Nov 2016||Reviewed||Reviewer Report - Johanna Damen|
|11 Dec 2016||Reviewed||Reviewer Report - Ben Van Calster|
|4 Jan 2017||Author responded||Author comments - Per Winkel|
|Resubmission - Version 3|
|4 Jan 2017||Submitted||Manuscript version 3|
|10 Jan 2017||Reviewed||Reviewer Report - Ben Van Calster|
|Resubmission - Version 4|
|Submitted||Manuscript version 4|
|11 Jan 2017||Editorially accepted|
|29 Mar 2017||Article published||10.1186/s41512-017-0009-y|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.